Frontiers in Immunology (Jul 2019)
Corrigendum: GSH-C4 Acts as Anti-inflammatory Drug in Different Models of Canonical and Cell Autonomous Inflammation Through NFκB Inhibition
- Dolores Limongi,
- Sara Baldelli,
- Paola Checconi,
- Maria Elena Marcocci,
- Giovanna De Chiara,
- Alessandra Fraternale,
- Mauro Magnani,
- Maria Rosa Ciriolo,
- Maria Rosa Ciriolo,
- Anna Teresa Palamara,
- Anna Teresa Palamara,
- Anna Teresa Palamara
Affiliations
- Dolores Limongi
- Department of Human Sciences and Promotion of the Quality of Life, IRCCS San Raffaele Pisana, San Raffaele Roma Open University, Rome, Italy
- Sara Baldelli
- Department of Human Sciences and Promotion of the Quality of Life, IRCCS San Raffaele Pisana, San Raffaele Roma Open University, Rome, Italy
- Paola Checconi
- Department of Human Sciences and Promotion of the Quality of Life, IRCCS San Raffaele Pisana, San Raffaele Roma Open University, Rome, Italy
- Maria Elena Marcocci
- Department of Public Health and Infectious Diseases, Sapienza University of Rome, Rome, Italy
- Giovanna De Chiara
- Institute of Translational Pharmacology, National Research Council Rome, Rome, Italy
- Alessandra Fraternale
- University of Urbino Carlo Bo, Department of Biomolecular Sciences, Urbino, Italy
- Mauro Magnani
- University of Urbino Carlo Bo, Department of Biomolecular Sciences, Urbino, Italy
- Maria Rosa Ciriolo
- Department of Biology, University of Rome “Tor Vergata”, Rome, Italy
- Maria Rosa Ciriolo
- IRCCS San Raffaele Pisana, Rome, Italy
- Anna Teresa Palamara
- Department of Public Health and Infectious Diseases, Sapienza University of Rome, Rome, Italy
- Anna Teresa Palamara
- IRCCS San Raffaele Pisana, Rome, Italy
- Anna Teresa Palamara
- Institute Pasteur-Fondazione Cenci Bolognetti, Rome, Italy
- DOI
- https://doi.org/10.3389/fimmu.2019.01481
- Journal volume & issue
-
Vol. 10
Abstract
No abstracts available.Keywords